Identification of VAR2CSA Domain-Specific Inhibitory Antibodies of the Plasmodium falciparum Erythrocyte Membrane Protein 1 Using a Novel Flow Cytometry Assay
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
VAR2CSA, a member of the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family, is a leading candidate for use in vaccines to protect first-time mothers from placental malaria (PM). VAR2CSA, which is comprised of a series of six Duffy binding-like (DBL) domains, binds chondroitin sulfate A (CSA) on placental syncytiotrophoblast. Several recombinant DBL domains have been shown to bind CSA. In order to identify and develop recombinant proteins suitable for clinical development, DBL2X and DBL3X, as well as their respective third subdomain (S3) from the FCR3 parasite clone, were expressed in Escherichia coli, refolded, and purified. All but DBL3X-S3 recombinant proteins bound to CSA expressed on Chinese hamster ovary (CHO)-K1 cells but not to CHO-pgsA745 cells, which are CSA negative as determined by flow cytometry. All but DBL3X-S3 bound to CSA on chondroitin sulfate proteoglycan (CSPG) as determined by surface plasmon resonance (SPR) analysis. Purified IgG from rats and rabbits immunized with these four recombinant proteins bound homologous and some heterologous parasite-infected erythrocytes (IE). Using a novel flow cytometry inhibition-of-binding assay (flow-IBA), antibodies against DBL3X-S3 inhibited 35% and 45% of IE binding to CSA on CHO-K1 cells compared to results for soluble CSA (sCSA) and purified multigravida (MG) IgG, respectively, from areas in Tanzania to which malaria is endemic. Antibodies generated against the other domains provided little or no inhibition of IE binding to CSA on CHO-K1 cells as determined by the flow cytometry inhibition-of-binding assay. These results demonstrate for the first time the ability to identify antibodies to VAR2CSA DBL domains and subdomains capable of inhibiting VAR2CSA parasite-IE binding to CSA by flow cytometry. The flow cytometry inhibition-of-binding assay was robust and provided an accurate, reproducible, and reliable means to identify blocking of IE binding to CSA and promises to be significant in the development of a vaccine to protect pregnant women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Smith, J. D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R., Newbold, C. I., & Miller, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90056-x · Cited by 1,005 · cited 2×
“During pregnancy, Plasmodium falciparum-infected erythrocytes (IE) bearing a preferentially expressed VAR2CSA protein are sequestered on placental syncytiotrophoblast by binding to chondroitin sulfate A (CSA) (1, 2, 3).”
BackgroundSelf-citationSalanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 4×
“Sequences for FCR3/IT4, 3D7/NF54, and HB3 were already available (13).”
BackgroundInfluentialMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Self-citationQuantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
Staalsoe, T., Shulman, C. E., Bulmer, J. N., Kawuondo, K., Marsh, K., & Hviid, L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15386-x · Cited by 288 · cited 1×
“However, over multiple pregnancies, women acquire blocking antibodies that bind the parasite-encoded VAR2CSA protein expressed on the surface of parasite-IE and are associated with better pregnancy outcomes (7, 8, 9, 10).”
BackgroundDuffy, P. E., & Fried, M. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6620-6623.2003 · Cited by 260 · cited 2×
“Whereas several DBL domains (DBL2X, DBL3X, and DBL5ε) have been shown to bind to CSA (7), single DBL”
BackgroundSelf-citationViebig, N. K., Gamain, B., Scheidig, C., Lépolard, C., Przyborski, J., Lanzer, M., Gysin, J., & Scherf, A. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400466 · Cited by 201 · cited 2×
“Gene disruption has been used to show that var2csa is the primary var gene responsible for CSA binding (11, 15, 17).”
BackgroundMethodClausen, T. M., Christoffersen, S., Dahlbäck, M., Langkilde, A. E., Jensen, K. E., Resende, M., Agerbæk, M. Ø., Andersen, D., Berisha, B., Ditlev, S. B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348839 · Cited by 173
Srivastava, A., Gangnard, S., Round, A., Dechavanne, S., Juillerat, A., Raynal, B., Faure, G., Baron, B., Ramboarina, S., Singh, S. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000951107 · Cited by 149
Gamain, B., Trimnell, A. R., Scheidig, C., Scherf, A., Miller, L. H., & Smith, J. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/428137 · Cited by 145 · cited 2×
“Previous work has suggested that the DBL2X and DBL3X domains contain CSA-binding activity, and binding activity has been mapped to the DBL3 subdomain 3 (12, 24, 40).”
BackgroundSelf-citationKhunrae, P., Dahlbäck, M., Nielsen, M. A., Andersen, G., Ditlev, S. B., Resende, M., Pinto, V. V., Theander, T. G., Higgins, M. K., & Salanti, A. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.040 · Cited by 121
Singh, K., Gittis, A. G., Nguyen, P., Gowda, D. C., Miller, L. H., & Garboczi, D. N. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1479 · Cited by 99
Self-citationNielsen, M. A., Pinto, V. V., Resende, M., Dahlbäck, M., Ditlev, S. B., Theander, T. G., & Salanti, A. (2009) · Infection and Immunity · doi:10.1128/iai.00159-09 · Cited by 92 · cited 1×
“Conversely, most single-domain antigens, with the exception of DBL4ε and DBL5ε, have elicited limited adhesion blocking activity (28, 29, 30, 31, 32).”
BackgroundDynamics of Anti‐VAR2CSA Immunoglobulin G Response in a Cohort of Senegalese Pregnant Women
Tuikue Ndam, N. G., Salanti, A., Le‐Hesran, J. ‐., Cottrell, G., Fievet, N., Turner, L., Sow, S., Dangou, J. ‐., Theander, T., & Deloron, P. (2006) · The Journal of Infectious Diseases · doi:10.1086/500146 · Cited by 89 · cited 1×
“Of interest, seroepidemiological studies of five of the six VAR2CSA DBL domains suggest that DBL3X and DBL5ε are more immunodominant than other domains (42, 43, 44).”
BackgroundStructural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA
Andersen, P., Nielsen, M. A., Resende, M., Rask, T. S., Dahlbäck, M., Theander, T., Lund, O., & Salanti, A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040042 · Cited by 79 · cited 1×
“VAR2CSA is a large multidomain protein ( 350 kDa) consisting of six Duffy-binding-like (DBL) domains, a cysteine-rich interdomain region (termed CIDRPAM), and other interdomain regions (13, 18).”
BackgroundVar2CSA minimal CSA binding region is located within the N-terminal region
Srivastava, A., Gangnard, S., Dechavanne, S., Amirat, F., Lewit Bentley, A., Bentley, G. A., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020270 · Cited by 76
Bigey, P., Gnidehou, S., Doritchamou, J., Quiviger, M., Viwami, F., Couturier, A., Salanti, A., Nielsen, M. A., Scherman, D., Deloron, P., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir499 · Cited by 63 · cited 4×
“The DBL2X domain is thought to be part of a “core” CSA-binding region (23, 33).”
BackgroundInfluentialOleinikov, A. V., Rossnagle, E., Francis, S., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/518513 · Cited by 59 · cited 1×
“Of interest, seroepidemiological studies of five of the six VAR2CSA DBL domains suggest that DBL3X and DBL5ε are more immunodominant than other domains (42, 43, 44).”
BackgroundSelf-citationBir, N., Yazdani, S. S., Avril, M., Layez, C., Gysin, J., & Chitnis, C. E. (2006) · Infection and Immunity · doi:10.1128/iai.00481-06 · Cited by 49
Self-citationAvril, M., Hathaway, M. J., Srivastava, A., Dechavanne, S., Hommel, M., Beeson, J. G., Smith, J. D., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016622 · Cited by 40 · cited 1×
“Whereas full-length VAR2CSA recombinant proteins are highly immunogenic, the adhesion blocking activity they elicited was strain specific (19, 27).”
BackgroundSelf-citationTowards a vaccine against pregnancy-associated malaria
Tuikue Ndam, N., & Deloron, P. (2008) · Parasite · doi:10.1051/parasite/2008153515 · Cited by 14 · cited 2×
“Expression of var2csa on IE is at high frequencies in laboratory parasite isolates selected for CSA binding and placental isolates (9, 13, 14).”
Background
Cited by
Doritchamou, J. Y. A., Herrera, R., Aebig, J. A., Morrison, R., Nguyen, V., Reiter, K., Shimp, R. L., MacDonald, N. J., Narum, D. L., Fried, M., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw197 · Cited by 35
Self-citationUtilizing nanobody technology to target non-immunodominant domains of VAR2CSA
Ditlev, S. B., Florea, R., Nielsen, M. A., Theander, T. G., Magez, S., Boeuf, P., & Salanti, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084981 · Cited by 31
Fried, M., Kurtis, J. D., Swihart, B., Morrison, R., Pond-Tor, S., Barry, A., Sidibe, Y., Keita, S., Mahamar, A., Andemel, N., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2258-9 · Cited by 30
Self-citationIyamu, U., Vinals, D. F., Tornyigah, B., Arango, E., Bhat, R., Adra, T. R., Grewal, S., Martin, K., Maestre, A., Overduin, M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1202276 · Cited by 7
Metadata
- Authors
- Obiakor, H., Avril, M., MacDonald, N. J., Srinivasan, P., Reiter, K., Anderson, C., Holmes, K. L., Fried, M., Duffy, P. E., Smith, J. D., Narum, D. L., & Miller, L. H.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2013-01-23
- Volume
- 20
- Issue
- 3
- Pages
- 433-442
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2086363181
- Cited by
- 22
- References
- 22
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.